Recruiting Chronic Urticaria Studies in Scottsdale
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) inadequately controlled by non-sedating ...
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)
The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) inadequately controlled by non-sedating ...
About Chronic Urticaria Clinical Trials in Scottsdale
Chronic urticaria involves recurring episodes of itchy, red welts (hives) lasting more than six weeks. Chronic spontaneous urticaria (CSU) occurs without an identifiable trigger. Treatment includes antihistamines and biologics like omalizumab.
There are currently 2 chronic urticaria clinical trials recruiting participants in Scottsdale, AZ. These studies are seeking a combined 1,830 participants. Research is being sponsored by Celldex Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Chronic Urticaria Clinical Trials in Scottsdale — FAQ
Are there chronic urticaria clinical trials in Scottsdale?
Yes, there are 2 chronic urticaria clinical trials currently recruiting in Scottsdale, AZ. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Scottsdale?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Scottsdale research site will contact you about next steps.
Are clinical trials in Scottsdale free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Scottsdale studies also compensate for your time and travel.
What chronic urticaria treatments are being tested?
The 2 active trials in Scottsdale are testing new therapies including novel drugs, biologics, and treatment approaches for chronic urticaria.
Data updated March 2, 2026 from ClinicalTrials.gov